NSE filing, NSE: QLINE. Summary written from the filing by ALFA Finder's alert engine.
Q-Line Biotech Ltd: key numbers
- Share price
- ₹525.05
- Market cap
- ₹1,225 Cr
- Revenue (annual)
- ₹341.7 Cr
- Net profit (annual)
- ₹55.72 Cr
- P/E (TTM)
- 22.0×Sector 52.3×
- Promoter holding
- 67.51%
- FII holding
- 0.87%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Q-Line Biotech Ltd
All →Q-Line Biotech Annual General Meeting
Q-Line Biotech Limited held its 16th Annual General Meeting on September 30, 2026. The meeting transacted ordinary and special business, including financial statement adoption and director re-appointments.
Q-Line Biotech Annual General Meeting
Q-Line Biotech has sent a letter to shareholders with bounced emails, providing links to the Annual Report and 16th AGM Notice, scheduled for September 30, 2026.
Q-Line Biotech Annual Report
Q-Line Biotech Limited has submitted its Annual Report for the financial year 2025-26. The full document is accessible via the provided company website link.
Q-Line Biotech Board Meeting Outcome
Q-Line Biotech approved the Board's Report, notice for the 16th AGM, and re-appointment of two Whole Time Directors and the Cost Auditor.
Q-Line Biotech Other Announcement
Q-Line Biotech Limited has re-appointed M/s. P S P & Associates as Cost Auditors for a 12-month term.
- Execution
- 12 months
Q-Line Biotech Partnership
Q-Line Biotech amended its license agreement with Boule Medical AB, Sweden. The revision includes a 25% reduction in license/royalty costs effective from July 2026.
- From
- Boule Medical AB
- Execution
- 5 years
Other other announcement announcements
All →Uniroyal Marine Exports Other Announcement
Uniroyal Marine Exports filed its shareholding pattern as of 30 September 2026. Some original promoters remain untraceable, and their remaining holdings are being dematerialised.
SGL Resources Other Announcement
SGL Resources filed its quarterly shareholding pattern for the quarter ended 30 September 2026. It shows routine holdings with no promoter transaction or corporate event.
Augmont Enterprises Other Announcement
Augmont Enterprises filed its quarterly shareholding pattern for the period ended 30 September 2026. The filing shows promoter holding of about 81.9% and public shareholding of about 18.1%.
Darshan Orna Other Announcement
Darshan Orna Limited filed its quarterly shareholding pattern as of 30 September 2026. The filing shows routine holding data with no transaction or corporate event.
Shanti Inorganics Other Announcement
Shanti Inorganics informs NSE that the Corporate Governance Report under Regulation 27(2) is not applicable for the quarter and half year ended 30 September 2026, as it is listed on the SME platform. Related party transaction compliance under Regulation 23 continues.
Transport Corporation of India Other Announcement
Transport Corporation of India disclosed its quarterly shareholding pattern for the period ended 30 September 2026. The filing is routine periodic compliance under SEBI Regulation 31.